title: [Clinical observation on effect of intervention therapy with anticoagulant in treating patients of hypertension complicated with acute ischemic cerebrovascular disease].
abstract: OBJECTIVE
  To study the changes of blood coagulation-fibrinolysis-C protein system in patients of hypertension with acute ischemic cerebrovascular disease (AICVD) after anticoagulation therapy.
  
  
  METHODS
  Fifty-seven cases of AICVD were grouped and treated with heparin and Xueshuantong (XST) respectively, and the levels of prothrombin time (PT), activated partial thromboplastin time (APTT), fibrinogen (FIB), tissue plasminogen activator (t-PA), plasminogen activator inhibitor (PAI) and activated protein C (APC) were determined before and after treatment.
  
  
  RESULTS
  The clinical markedly effective rate in the heparin group and the XST group was 69.2% and 67.7% respectively with no significant difference (P > 0.05). In the heparin group, level of PT and APTT prolonged, FIB decreased, t-PA activity elevated and PAI activity lowered, and APC unchanged. In the XST group, same changes in FIB, t-PA and PAI were shown but with APC increased, and PT and APTT unchanged.
  
  
  CONCLUSIONS
  Both heparin and XST have good anticoagulatory function and show good clinical effect in treating patients with hypertension complicated with acute ischemic cerebrovascular diseases.
authors.affiliation: Department of Hypertension, People's Hospital of Beijing University, Beijing 100044.
authors.forename: Q C
authors.initials: QC
authors.lastname: Ma
authors.forename: J S
authors.initials: JS
authors.lastname: Ma
authors.forename: N L
authors.initials: NL
authors.lastname: Sun
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000627:therapeutic use*; D002545:Brain Ischemia / Q000188:drug therapy* / Q000209:etiology; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use*; D005260:Female; D005340:Fibrinogen / Q000378:metabolism; D036145:Ginsenosides / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000150:complications*; D008297:Male; D008875:Middle Aged; D005894:Panax / Q000737:chemistry; D008517:Phytotherapy; D010959:Tissue Plasminogen Activator / Q000378:metabolism
chemical_list: D000925:Anticoagulants; D004365:Drugs, Chinese Herbal; D036145:Ginsenosides; D005340:Fibrinogen; D010959:Tissue Plasminogen Activator